Patent · US Active

Antiviral vaccines with improved cellular immunogenicity

US9017691B2 · kind B2 · utility

46Cited by

0References

23Claims

0Family size

Assignees

Beth Israel Deaconess Medical Center, Inc. · US
LOS ALAMOS NATIONAL SECURITY, LLC · US

Inventors

Dan H. Barouch · Newton, US
Bette T. Korber · Los Alamos, US
William M. Fischer · Los Alamos, US

Key dates

Filing date	Nov 18, 2009
Grant date	Apr 28, 2015
Priority date	—
Expiry date	Jun 16, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compositions, methods, and kits for the treatment or prevention of viral infections. The polyvalent (e.g., 2-valent) vaccines described herein incorporate computationally-optimized viral polypeptides that can increase the diversity or breadth and depth of cellular immune response in vaccinated subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.